Nursing care
Exogenous surfactant: dosing-time safety, ventilator changes and suctioning limits
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
Exogenous surfactant is instilled into the trachea of a preterm newborn with respiratory distress syndrome to lower alveolar surface tension. The nurse confirms tube position, watches for bradycardia, desaturation and tube blockage during dosing, expects rapid improvement in lung compliance that may need prompt ventilator and oxygen changes, and avoids routine suctioning for about an hour afterwards.
What replacement surfactant does in the preterm lung
Natural surfactant keeps small alveoli from collapsing at the end of each breath. Preterm lungs often make too little, causing stiff lungs and respiratory distress syndrome. Replacement products, derived from animal lungs or made synthetically, are delivered straight into the airway so they can spread across the alveolar surface and restore compliance, which is how easily the lung inflates.
Surfactant may be given prophylactically to high-risk infants or as rescue treatment once distress is established, depending on unit criteria. Delivery is usually through an endotracheal tube, though less invasive techniques with a thin catheter and supraglottic devices are also used. The drug acts within the lungs, so the nursing focus is airway, oxygenation and ventilation rather than systemic side effects.
Preparing the infant and the tube
Labels require that dosing happen in a supervised setting with staff experienced in intubation and neonatal ventilation. Before the dose, the team confirms endotracheal tube placement and patency, because surfactant delivered into one main bronchus or down a partly blocked tube will not spread evenly. The tube may be suctioned before dosing if clinically needed, and continuous pulse oximetry and heart rate monitoring are in place.
Positioning depends on the product. One porcine product is given with the infant's head and body aligned in a neutral position, while a bovine product is split into aliquots with the infant tilted and turned between them. The common goal is even distribution, so the nurse follows the specific product instructions rather than one memorised position.
Events during dosing and the immediate response
Labels describe transient bradycardia, oxygen desaturation, hypotension and endotracheal tube blockage as the commonest dosing problems. The liquid can briefly fill the airway or provoke reflux up the tube. The labelled response is to stop instillation, support ventilation and oxygen until the infant stabilises, and then resume dosing. Escalate if heart rate or saturation does not recover.
Moist breath sounds and crackles are expected for a while after dosing and do not by themselves need suctioning. Significant airway obstruction is different: poor chest rise, rising carbon dioxide, a sudden fall in saturation or loss of breath sounds suggests a blocked tube. Labels advise against suctioning for about one hour after instillation unless such obstruction develops.
Ventilator and oxygen changes after the dose
Surfactant can improve oxygenation and compliance within minutes. Settings that were right before the dose may suddenly be too high, and excessive pressure in newly compliant lungs raises the risk of air leak such as pneumothorax. Labels and reference texts stress frequent blood gas or transcutaneous monitoring so that inspired oxygen and inflation pressures can be weaned promptly.
Some infants need a brief increase in support during dosing, so the trend matters more than any single reading. The nurse reports rapidly rising saturation, falling oxygen needs and improved chest movement so the provider or respiratory therapist can adjust settings. A sudden deterioration after initial improvement raises concern for pneumothorax or tube problems and needs urgent assessment.
Applying the priorities to a study scenario
Picture a hypothetical ventilated preterm infant who received surfactant twenty minutes ago. Saturation has climbed above the target range and chest movement looks much larger than before. The options are to suction the tube to clear the remaining drug, increase oxygen to protect the brain, notify the provider for ventilator weaning, or reposition the infant prone.
Notifying the team so oxygen and pressure can be weaned is the best choice, because this is the expected compliance response and over-ventilation risks air leak and oxygen toxicity. Routine suctioning would remove drug within the restricted window, extra oxygen worsens hyperoxia, and repositioning does not address the settings. This is a study scenario, not a real NCLEX item.
Sources and further reading
DailyMed: Curosurf (poractant alfa) prescribing information. Tube placement checks, neutral positioning, transient bradycardia, desaturation and tube blockage, one-hour suction restriction and ventilator adjustments.
DailyMed: Survanta (beractant) prescribing information. Aliquot positioning, frequent blood gas monitoring, expected moist breath sounds, suction restriction and supervised setting requirements.
MSD Manual Professional: Respiratory distress syndrome in neonates. Prophylactic and selective surfactant use, less invasive delivery, rapid compliance change and the need to lower pressures to reduce air leak.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our maternity and newborn practice questions are the closest set to what this page covers.
Common questions
Why is suctioning avoided right after surfactant?
Suctioning soon after instillation can remove drug before it spreads into the alveoli. Labels advise avoiding it for about an hour unless there are signs of significant airway obstruction.
Are crackles after surfactant a sign of a problem?
Not on their own. Moist breath sounds are expected for a time after dosing. Poor chest rise, falling saturation or rising carbon dioxide point toward obstruction and need action.
What should the nurse do if bradycardia occurs during dosing?
Stop instilling the drug, support ventilation and oxygenation until heart rate and saturation recover, then continue only when the infant is stable, following the product label and the team's direction.